PERITONEAL DIALYSIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global peritoneal dialysis market is estimated to be valued at USD 9.42 Bn in 2024 and is expected to reach USD 13.90 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. Global peritoneal dialysis market growth is driven by rising prevalence of chronic kidney disease and growing demand for home hemodialysis treatment. Peritoneal dialysis is a kidney replacement therapy performed using fluid and electrolyte exchange through the peritoneal membrane in the abdomen. It offers various advantages over conventional hemodialysis such as fewer dietary restrictions, improved quality of life, and better fluid management. Moreover, growing geriatric population prone to chronic diseases and increasing healthcare expenditure in developing nations can boost demand for peritoneal dialysis procedures. However, factors such as lack of experienced nephrologists and reimbursement issues in some countries may hamper the market growth.

Market Dynamics

Key drivers propelling the global peritoneal dialysis market growth include growing prevalence of diabetes and hypertension leading to end-stage renal disease, favorable reimbursement policies for home dialysis therapies in developed nations, and increasing demand for chronic kidney disease treatment alternatives to hospital-based hemodialysis. Benefits of peritoneal dialysis over hemodialysis such as improved quality of life, flexibility, and less dietary restrictions boosts its adoption rates. However, shortage of trained nephrologists especially in developing and underdeveloped regions and risk of peritonitis with long-term peritoneal dialysis pose challenges. Moreover, lack of dialysis infrastructure in remote areas can also hamper the market growth. Ongoing innovations in peritoneal dialysis machines, catheters and solutions aimed at enhancing efficacy and patient comfort offer opportunities for market expansion.

Key Features of the Study

- This report provides in-depth analysis of the global peritoneal dialysis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year

- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

- It profiles key players in the global peritoneal dialysis market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies

- Key companies covered as a part of this study include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Cook Medical, Asahi Kasei Medical Co., Ltd., Gambro (part of Fresenius), Dialife SA, Renal Solutions, Inc., Toray Industries, Inc., Nihon Kohden Corporation, Baxter Healthcare Corporation, SWS Hemodialysis Care, Inc., and Astellas Pharma Inc.

- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

- Global peritoneal dialysis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peritoneal dialysis market

Market Segmentation

•  Product Types Insights (Revenue, USD Bn, 2019 - 2031)
• • Peritoneal Dialysis Solutions
  • Peritoneal Dialysis Catheters
  • Peritoneal Dialyzers
  • Implantation Systems
•  Applications Insights (Revenue, USD Bn, 2019 - 2031)
• • Automated Peritoneal Dialysis (APD)
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
•  End User Insights (Revenue, USD Bn, 2019 - 2031)
• • Hospitals
  • Home Care Settings
  • Dialysis Centers
  • Research Institutes
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Medtronic plc
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Cook Medical
  • Asahi Kasei Medical Co., Ltd.
  • Gambro (part of Fresenius)
  • Dialife SA
  • Renal Solutions, Inc.
  • Toray Industries, Inc.
  • Nihon Kohden Corporation
  • Baxter Healthcare Corporation
  • SWS Hemodialysis Care, Inc.
  • Astellas Pharma Inc.